BlueWind Medical, Ltd., a leader in Implantable Tibial Neuromodulation (ITNM) and developer of the Revi® System, a ...

Key findings included 94% of test-phase responders experienced at least a 50% decrease in episodes of UUI.

First customer sites include the University of Arkansas for Medical Sciences, MUSC Health, and Calif.-based Acacia Clinics and Kaizen Brain Center BURLINGAME, Calif.--(BUSINESS WIRE)--Magnus Medical, ...

Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults ...

The Louisiana-based company offers its Ellipse Spinal Cord Stimulator Platform for treating chronic pain. The platform includes the company's patented and FDA-cleared StimuLux technology, which uses ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s and ...

The International Neuromodulation Society (INS) journal Neuromodulation: Technology at the Neural Interface is publishing expert, evidence-based guidance on the safe and efficient use of ...

Review publication details benefits of repetitive transcranial magnetic stimulation (rTMS) on Alzheimer’s, including increases in neuroplasticity and other structural and functional second order ...

This post was co-authored by Abigail Ramos and Robert T. Muller, Ph.D. With the development of new neuro-technology and emerging research on the function of the brain, the treatment of mental illness ...